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Introduction: Congenital adrenal hyperplasia (CAH) due to 21-Hydroxylase deficiency occurs in 90-95% of cases, being a 
common autosomal   recessive condition  that can present with a wide range of hyperandrogenemic signs in childhood or 
adulthood. Severity of this disease is correlated with the enzymatic blockade of 21-Hydroxylase   which depends of the 
mutation  in gene CYP21A2. Two clinical forms are possible: classic, subdivided   in salt-wasting and simple virilizing form 
(severe) and nonclassic or late onset (less severe). 
Aims: We studied two portuguese families with NCCAH due to 21-Hidroxilase deficiency in order to improve clinical 
management and genetic counseling of their members. 
Methods: Clinical presentation and hormonal assays (including test of tetracosactide) were performed  in  index cases  (IC) 
. Genomic DNA of each family member was sequenced for the 9 most frequent mutations in CYP21A2. Total  deletion  of 
 CYP21A , conversion  in  non functioning  CYP21A1P  or CYP21A1P_ CYP21A2  quimeras were also analyzed by 
enzymatic restriction. 
Results: Family 1- IC: Female, 31 years old  with  NCCAH  diagnosed  at age 6 , after investigation of  precocious  
pubarche  and  with  test of  tetracosactide positive (17-alpha hydroxyprogesterone   levels  > 10-15 ng/ml) . Molecular study 
of   CYP21A2 showed a mutation  g.1683G> T  ,  homozygous ,  in CYP21A2 and  a non functioning allele of CYP21A2 , 
 heterozygous  (non  severe 21-Hidroxilase deficiency).  Mother  was  carrying   a  non functioning  allele of CYP21A2 ,  
heterozygous  (severe); Father, Brother and Partner  were heterozygous for  mutation  g.1683G> T  (non severe). 
Family 2- IC: Female,  45 years old  presenting   hirsutism and oligoamenorrhea  at  age  35 and  with  test of  tetracosactide 
 positive confirming  NCCAH Genetic study identified   mutation g.1683G> T   (less severe)   in a copy and  g.655A/C>G  in 
another copy (splicing  mutation  severe).  Familial   genetic study   identified two sisters (age 36 and age 40), asymptomatic 
but with pathologic genotype confirming NCCAH. 
Discussion: Affected individuals or carriers of severe mutation in CYP21A2 can have descendents with the classic form if 
their partners are also carriers of severe mutations. 
Preconception genetic study  of   the couple (Family 1) suggests a   probability of  50% in which pregnancy,  for 
descendents with 21-Hidroxilase deficiency nonclassic form. In Family 2, genetic studies will be performed in descendents of 
affected individuals after age 18 or before, if they are symptomatic or considering pregnancy. 
Preconception genetic study in the context of a medical genetic consultation is fundamental in programming   pregnancy, 
preventing therapies and unnecessary anxiety. 
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